- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06471660
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
Influence of Swallowing Impairment on Burden Among Caregivers of Persons With Alzheimer's Disease and Related Dementias
Study Overview
Status
Detailed Description
This research aims to increase our understanding of dysphagia-related caregiver burden and inform the development of a comprehensive dysphagia intervention, one that promotes the health and quality of life of both the caregiver and the person with dementia.
Aim 1. Quantify dysphagia's contribution to burden among family caregivers of persons with dementia across the disease trajectory to identify when may be best to intervene.
Aim 2. Characterize the moderating effects of caregiver readiness and support on dysphagia-related burden and care recipient quality of life to identify what are the most appropriate intervention targets.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Oregon
-
Eugene, Oregon, United States, 97403
- Remote study offered by the University of Oregon
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Be a caregiver for a family member (or chosen family member) with dementia
- Have been caregiving for at least 2 months
- Live at home with the care recipient
- Not be paid for the care provided
- Be over the age of 18
- Live in the US
Exclusion Criteria:
- Not be a caregiver for a family member (or chosen family member) with dementia
- Have been caregiving for less than 2 months
- Not live at home with the care recipient
- Be paid for the care provided
- Be under the age of 18
- Live outside in the US
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Demographic Information
Time Frame: Baseline
|
Demographic Questionnaire
|
Baseline
|
|
Eight-item Informant Interview to Differentiate Aging and Dementia (AD8)
Time Frame: Baseline
|
The AD8 is a screening test that is sensitive to detecting early cognitive changes associated with dementia.
AD8 is a scale from 0-8, with higher scores signifying more severe cognitive decline.
|
Baseline
|
|
Global Deterioration Scale (GDS)
Time Frame: Baseline
|
The Global Deterioration Scale (GDS) provides an overview of the stages of cognitive function for those suffering from a primary degenerative dementia such as Alzheimer's disease.
GDS is a scale from 0-7, with higher scores signifying more severe cognitive decline.
|
Baseline
|
|
International Dysphagia Diet Standardisation Initiative Functional Diet Scale (IDDSI-FDS)
Time Frame: Baseline
|
The IDDSI-FDS is a validated tool that was created in order to capture degree of diet texture restriction.
Degree of diet texture restriction has been previously used in the literature as a self- or informant-reported proxy measure for dysphagia severity given that it represents the functional impact of the dysphagia on daily eating.
The scale ranges from 0-8, higher scores indicating less diet texture restriction.
|
Baseline
|
|
Zarit Burden Interview
Time Frame: Baseline
|
The Zarit Burden Interview is a valid, reliable, and widely used self-report measure designed to quantify general caregiver burden, incorporating both objective and subjective burden.
It queries common areas of concern, including those related to finances, health, social life, and interpersonal relationships, and explores both personal and role strain.
Scores range from 0-88, with higher scores signifying more burden.
|
Baseline
|
|
Caregiver Analysis of Reported Experiences with Swallowing (CARES)
Time Frame: Baseline
|
The CARES is a valid and reliable questionnaire designed to screen for dysphagia-related caregiver burden.
The 26-item questionnaire explores the potentially burdensome, more objective behavioral and functional changes that have occurred as a result of dysphagia (Part A) and the more subjective stressors experienced by the caregiver (Part B).
Scores range from 0-26, with higher scores signifying more dysphagia-related caregiver burden.
|
Baseline
|
|
Caregiving Competence Scale
Time Frame: Baseline
|
The Caregiving Competence Scale, developed for caregivers of persons with dementia and adapted for dysphagia management, is a valid and reliable four-item scale measuring caregivers' perceived adequacy of their own performance.
Scores range from 0-12, with higher scores signifying more perceived competence.
|
Baseline
|
|
Dysphagia-Related Knowledge Questionnaire
Time Frame: Baseline
|
The Dysphagia-Related Knowledge Questionnaire is a study-specific measure assessing caregiver knowledge of functional aspects of dysphagia and dysphagia management, including key definitions, signs/symptoms, management techniques, consequences, and the dysphagia trajectory.
Scores can range from 0-13, with higher scores signifying more dysphagia-related knowledge.
|
Baseline
|
|
Preparedness for Caregiving Scale
Time Frame: Baseline
|
The Preparedness for Caregiving Scale, adapted for dysphagia management, explores caregivers' perceived preparation related to caring for the physical and emotional needs of their care recipient.
Scores range from 0-12, with higher scores signifying more perceived preparedness.
|
Baseline
|
|
Multidimensional Scale of Perceived Social Support (MSPSS)
Time Frame: Baseline
|
The MSPSS is a self-report measure of subjectively assessed social support that has been validated for use within a variety of populations across the lifespan.
Scores range from 12-84, with higher scores signifying more perceived social support.
|
Baseline
|
|
Eating Assessment Tool 10 (EAT-10)
Time Frame: Baseline
|
The EAT-10 is a validated, widely used clinically, and easy-to-administer 10-item symptom-specific swallowing outcomes tool designed to understand the extent to which an individual's quality of life has been impacted by dysphagia.
While generally completed by patients themselves, previous research has suggested that proxies can reliably report on observable symptoms, such as those rated on the EAT-10 related to swallow function.
Scores range from 0-40, with higher scores signifying more severe dysphagia symptoms and greater impact to quality of life.
|
Baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Samantha Shune, The University of Oregon
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Synucleinopathies
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Mental Disorders
- Neoplasms
- Immune System Diseases
- Neoplasms by Histologic Type
- Digestive System Diseases
- Gastrointestinal Diseases
- Neurocognitive Disorders
- Tauopathies
- Neurodegenerative Diseases
- Esophageal Diseases
- Lymphatic Diseases
- Lymphoproliferative Disorders
- Immunoproliferative Disorders
- Lymphoma, Non-Hodgkin
- Otorhinolaryngologic Diseases
- Lymphoma
- Movement Disorders
- Pharyngeal Diseases
- Parkinsonian Disorders
- Basal Ganglia Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Leukoencephalopathies
- Intracranial Arteriosclerosis
- Intracranial Arterial Diseases
- Frontotemporal Lobar Degeneration
- Frontotemporal Dementia
- Hemic and Lymphatic Diseases
- Mixed Dementias
- Alzheimer Disease
- Lymphoma, Follicular
- Deglutition Disorders
- Dementia
- Pick Disease of the Brain
- Dementia, Vascular
- Lewy Body Disease
Other Study ID Numbers
- STUDY00000738
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
The University of Hong KongNot yet recruiting
-
NYU Langone HealthRecruiting
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan